Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion.

about

Valproate Attenuates 25-kDa C-Terminal Fragment of TDP-43-Induced Neuronal Toxicity via Suppressing Endoplasmic Reticulum Stress and Activating Autophagy.Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach.

P2860

Q35739624-6F128D0F-B927-4784-8670-4CEBD55E048B Q39102149-E0903A1F-8215-485A-83BE-C135829EA50B

P2860

Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion.

Item

http://www.wikidata.org/entity/Q42100957

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.

@en

Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.

@nl

type

Item

label

Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.

@en

Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.

@nl

prefLabel

Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.

@en

Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.

@nl

P1476

Valproate Treatment in an ALS ...... n and SMN2 Homozygous Deletion

@en

P2093

Antonella Fogli

http://www.w3.org/2001/XMLSchema#string

Massimo Corbo

http://www.w3.org/2001/XMLSchema#string

Paolo Simi

http://www.w3.org/2001/XMLSchema#string

Silvana Penco

http://www.w3.org/2001/XMLSchema#string

Virginia Rodriguez-Menendez

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid

An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.

Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis

A high-density genome-wide association screen of sporadic ALS in US veterans

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III

VPA response in SMA is suppressed by the fatty acid translocase CD36.

Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice.

Epigenetic regulation of motor neuron cell death through DNA methylation.

SMN1 gene duplications are associated with sporadic ALS.

P304

216094

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/216094

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264989457

http://www.w3.org/2001/XMLSchema#string

P698

25143843

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

4124810

http://www.w3.org/2001/XMLSchema#string

Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion.

about

P2860

P2860

Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932